INSULIN GENE-DERIVED PROTEINS AND PEPTIDES FOR USE IN THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

The present invention relates to the identification of novel peptides derived from aberrant proteins involved in Type 1 Diabetes mellitus (T1D), also known as defective ribosomal products (DRiPs). In particular the invention relates to epitopes present in DRiPs of the human preproinsulin (PPI) mRNA,...

Full description

Saved in:
Bibliographic Details
Main Authors VAN LUMMEL, Menno, VAN VEELEN, Peter Antonis, ZALDUMBIDE, Arnaud, ROEP, Bart Otto
Format Patent
LanguageEnglish
Published 31.10.2019
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Online AccessGet full text

Cover

Abstract The present invention relates to the identification of novel peptides derived from aberrant proteins involved in Type 1 Diabetes mellitus (T1D), also known as defective ribosomal products (DRiPs). In particular the invention relates to epitopes present in DRiPs of the human preproinsulin (PPI) mRNA, its representative peptides and the use thereof in diagnosis, prevention and/or treatment of T1D. Moreover, the inventions relate to antibodies and antisera against the identified epitopes and the use thereof in the diagnosis of T1D.
AbstractList The present invention relates to the identification of novel peptides derived from aberrant proteins involved in Type 1 Diabetes mellitus (T1D), also known as defective ribosomal products (DRiPs). In particular the invention relates to epitopes present in DRiPs of the human preproinsulin (PPI) mRNA, its representative peptides and the use thereof in diagnosis, prevention and/or treatment of T1D. Moreover, the inventions relate to antibodies and antisera against the identified epitopes and the use thereof in the diagnosis of T1D.
Author VAN VEELEN, Peter Antonis
ROEP, Bart Otto
VAN LUMMEL, Menno
ZALDUMBIDE, Arnaud
Author_xml – fullname: VAN LUMMEL, Menno
– fullname: VAN VEELEN, Peter Antonis
– fullname: ZALDUMBIDE, Arnaud
– fullname: ROEP, Bart Otto
BookMark eNqNyr0KwjAYheEMOvh3Dx84F1o7SMdoTtuAJiX5KjiVonGStlDvHyt6AU6Hl_Msxazru7AQd218fdKGChhECk5foKhyljE9JM0UqFgreMqto9qDJs0lSGlZGOv1V7GD5DMMk82JrxUo-YgDGH4t5o_2OYbNb1dim4OPZRSGvgnj0N5CF15N7XdxkqVpvMv2Mkn_U29BLza4
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
ExternalDocumentID US2019330297A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2019330297A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:11:07 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2019330297A13
Notes Application Number: US201716071900
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191031&DB=EPODOC&CC=US&NR=2019330297A1
ParticipantIDs epo_espacenet_US2019330297A1
PublicationCentury 2000
PublicationDate 20191031
PublicationDateYYYYMMDD 2019-10-31
PublicationDate_xml – month: 10
  year: 2019
  text: 20191031
  day: 31
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies ACADEMISCH ZIEKENHUIS LEIDEN
RelatedCompanies_xml – name: ACADEMISCH ZIEKENHUIS LEIDEN
Score 3.2397356
Snippet The present invention relates to the identification of novel peptides derived from aberrant proteins involved in Type 1 Diabetes mellitus (T1D), also known as...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Title INSULIN GENE-DERIVED PROTEINS AND PEPTIDES FOR USE IN THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191031&DB=EPODOC&locale=&CC=US&NR=2019330297A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8Q_HxT1PiBpolmb4uMFZo9EDPWTmZkW1hH8Im4DxITM4jM-O97HaA88djepenX9e7X3l0BHigqXYMmhp6h9tBpNzV1ixm5nrQyivY70qgKTh763UFMXyadSQ0-N7EwVZ7Qnyo5IkpUivJeVuf14v8Si1e-lcvH5AOr5k-u7HFtjY4RfOAm1Xi_J8KAB47mOL040vxRRUPo3raYjVhpTxnSKtO-GPdVXMpiW6m4J7AfYntFeQq1vGjAkbP5e60Bh8P1k3cDDiofzXSJlWs5XJ5Bhpg7fvV8ojzPdI5gbCw4CUeBFEghto8FEUqPi4ggzCNxJAhyy4Eg3LOf_SDyVlxyJGyp8vmTwCXyLRTEUBx9IUV0DveukM5Ax45P_-ZpGkfbozQvoF7Mi_wSiPmORlFmsFmLzWg7sxJcubxjsizpMsYs6wqau1q63k2-gWNVXB3oTaiXX9_5LWrqMrmrJvgXV4SMzw
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8Q_MA3RY0fqE00e1tkrNDsgZixdm4K28I6gk_EsZGYmEFkxn_f2wDlicf1d2nW667XX3t3A3ig6HQ1Gmtqgt5DpZ2prhpMS9W4mVDcvyNGi-TkgddxIvoybo8r8LnJhSnrhP6UxRHRoqZo73m5Xi_-D7F4GVu5fIw_sGn-ZMsuV9bsGMkHfqQK73VF4HPfUiyrG4WKNywxpO4tg5nIlfYYksKi0r4Y9Yq8lMW2U7GPYT_A_rL8BCppVoeatfn3Wh0OB-sr7zoclDGa0yU2ru1weQoJcu6o73qkiDxTOZKxkeAkGPpSIEJMDx9EIF0uQoI0j0ShICgtHUG4az57fuiupORQmLKo5098m8i3QBCtkOgJKcIzuLeFtBwVX3zyp6dJFG6PUj-HajbP0gsg-jtuihKNzZpsRluJEePMpW2dJXGHMWYYl9DY1dPVbvgOao4c9Cc46tdrOCqg1eLegGr-9Z3eoNfO49tS2b8T5Y-6
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INSULIN+GENE-DERIVED+PROTEINS+AND+PEPTIDES+FOR+USE+IN+THE+DIAGNOSIS+AND+TREATMENT+OF+TYPE+1+DIABETES&rft.inventor=VAN+LUMMEL%2C+Menno&rft.inventor=VAN+VEELEN%2C+Peter+Antonis&rft.inventor=ZALDUMBIDE%2C+Arnaud&rft.inventor=ROEP%2C+Bart+Otto&rft.date=2019-10-31&rft.externalDBID=A1&rft.externalDocID=US2019330297A1